載入...
Association between bevacizumab-related hypertension and response to treatment in patients with metastatic colorectal cancer
BACKGROUND: Bevacizumab has become standard of care as first-line treatment of metastatic colorectal cancer (mCRC), after proving increased response rates and improvement in survival outcomes. Hypertension (HTN) is a common complication of the treatment with bevacizumab and, owing to its close relat...
Na minha lista:
發表在: | ESMO Open |
---|---|
Main Authors: | , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
BMJ Publishing Group
2016
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5070256/ https://ncbi.nlm.nih.gov/pubmed/27843607 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2016-000045 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|